相关实验视频
Updated: Sep 8, 2025

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
346
肥胖,饮食模式和心血管疾病:对代谢和分子途径的叙述性审查
Cristina Dina1, Delia Mirela Tit1,2, Ada Radu1,2
1Doctoral School of Biological and Biomedical Sciences, University of Oradea, 410087 Oradea, Romania.
Current issues in molecular biology
|July 23, 2025
概括
肥胖会通过炎症和胰岛素抵抗加剧心血管疾病 (CVD). 饮食干预可以调节分子通路,改善代谢健康和心血管疾病风险因素,以获得更好的心血管结果.
科学领域:
- 心血管科学 心血管科学
- 代谢健康 代谢健康
- 营养科学 营养科学
背景情况:
- 心血管疾病 (CVD) 是全球主要的死亡原因.
- 肥胖通过慢性炎症,胰岛素抵抗和内皮功能障碍显著促进心血管疾病.
- 了解链接肥胖,饮食和心血管疾病的分子途径对于有效管理至关重要.
研究的目的:
- 审查肥胖,营养状况和心血管疾病进展之间的关系.
- 评估各种饮食干预措施对心血管健康的影响.
- 阐明分子途径在与肥胖有关的心血管疾病中的作用.
主要方法:
- 关于肥胖,饮食和心血管疾病研究的文献综述.
- 分析分子机制,包括脂质代谢,氧化应激和炎症信号.
- 评估特定的饮食模式:低碳水化合物,地中海,性和DASH饮食.
主要成果:
- 阿迪波金,互白蛋白和瘤亡因子α是肥胖相关心血管疾病中炎症和胰岛素抵抗的关键媒介.
- 饮食干预可以调节关键的分子通路,改善心血管风险因素.
- 特定的饮食显示出增强新陈代谢健康和减轻心血管功能障碍的潜力.
结论:
- 优化饮食策略对于管理肥胖个体的心血管疾病至关重要.
- 了解分子代谢途径对于个性化的营养方法至关重要.
- 需要进一步的研究来完善维持心血管健康的饮食策略.
相关概念视频
Obesity
609
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
609
Coronary Artery Disease I: Introduction
54
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
54
Overview of Lipid Metabolism
2.4K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
2.4K
Regulation of Metabolism
9.8K
Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
9.8K
Coronary Artery Disease II: Pathophysiology
33
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
33
Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33

